I-Mab Biopharma
IMAB
#9469
Rank
HK$0.43 B
Marketcap
HK$5.29
Share price
-6.87%
Change (1 day)
-63.11%
Change (1 year)

Earnings for I-Mab Biopharma (IMAB)

Earnings in 2024 (TTM): -HK$1.54 Billion

According to I-Mab Biopharma's latest financial reports the company's current earnings are HK$3.58 Million. In 2023 the company made an earning of -HK$0.23 Billion, an increase over its 2022 earnings that were of -HK$0.41 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for I-Mab Biopharma from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$1.54 Billion576.59%
2023 -HK$0.23 Billion-44.5%
2022-HK$0.41 Billion-8.36%
2021-HK$0.45 Billion-605.96%
2020 HK$88.32 M-138.32%
2019 -HK$0.24 Billion260.14%
2018 -HK$64 Million19.49%
2017-HK$53.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.15 Billion-90.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$80.57 Million-94.74%๐Ÿ‡บ๐Ÿ‡ธ USA